Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gianluca Veggiani

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Protein Expression and Purification|March 23, 2011
Improved quantitative and qualitative production of single-domain intrabodies mediated by the co-expression of Erv1p sulfhydryl oxidaseGianluca Veggiani, Ario de Marco
Cold Spring Harbor Protocols|May 17, 2023
Phage-Displayed SH2 Domain Libraries: From Ultrasensitive Tyrosine Phosphoproteome Probes to Translational ResearchGregory D Martyn, Gianluca Veggiani
Cold Spring Harbor Protocols|June 9, 2023
Beyond Natural Immune Repertoires: Synthetic AntibodiesGianluca Veggiani, Sachdev S Sidhu
Cold Spring Harbor Protocols|June 9, 2023
Generation and Selection of Synthetic Human Antibody Libraries via Phage DisplayGianluca Veggiani, Sachdev S Sidhu
Trends in Biotechnology|August 30, 2014
Superglue from bacteria: unbreakable bridges for protein nanotechnologyGianluca Veggiani, Bijan Zakeri, Mark Howarth
Cancer Research|February 5, 2013
Cholesterol loading and ultrastable protein interactions determine the level of tumor marker required for optimal isolation of cancer cellsJayati Jain, Gianluca Veggiani, Mark Howarth
Proceedings of the National Academy of Sciences of the United States of America|March 19, 2014
SpyLigase peptide-peptide ligation polymerizes affibodies to enhance magnetic cancer cell captureJacob O Fierer, Gianluca Veggiani, Mark Howarth
Methods in Molecular Biology (Clifton, N.J.)|September 5, 2023
Engineering SH2 Domains with Tailored Specificities and AffinitiesGregory D Martyn, Gianluca Veggiani, Sachdev S Sidhu
Cells|August 26, 2023
Ubiquitin Engineering for Interrogating the Ubiquitin-Proteasome System and Novel Therapeutic StrategiesJason Q Tang, Mary M Marchand, Gianluca Veggiani
Pharmacology & Therapeutics|March 10, 2019
Emerging drug development technologies targeting ubiquitination for cancer therapeuticsGianluca Veggiani, María Carla Rosales Gerpe, Sachdev S Sidhu, et al.
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Protein Expression and Purification|March 23, 2011
Improved quantitative and qualitative production of single-domain intrabodies mediated by the co-expression of Erv1p sulfhydryl oxidaseGianluca Veggiani, Ario de Marco
Cold Spring Harbor Protocols|May 17, 2023
Phage-Displayed SH2 Domain Libraries: From Ultrasensitive Tyrosine Phosphoproteome Probes to Translational ResearchGregory D Martyn, Gianluca Veggiani
Cold Spring Harbor Protocols|June 9, 2023
Beyond Natural Immune Repertoires: Synthetic AntibodiesGianluca Veggiani, Sachdev S Sidhu
Cold Spring Harbor Protocols|June 9, 2023
Generation and Selection of Synthetic Human Antibody Libraries via Phage DisplayGianluca Veggiani, Sachdev S Sidhu
Trends in Biotechnology|August 30, 2014
Superglue from bacteria: unbreakable bridges for protein nanotechnologyGianluca Veggiani, Bijan Zakeri, Mark Howarth
Cancer Research|February 5, 2013
Cholesterol loading and ultrastable protein interactions determine the level of tumor marker required for optimal isolation of cancer cellsJayati Jain, Gianluca Veggiani, Mark Howarth
Proceedings of the National Academy of Sciences of the United States of America|March 19, 2014
SpyLigase peptide-peptide ligation polymerizes affibodies to enhance magnetic cancer cell captureJacob O Fierer, Gianluca Veggiani, Mark Howarth
Methods in Molecular Biology (Clifton, N.J.)|September 5, 2023
Engineering SH2 Domains with Tailored Specificities and AffinitiesGregory D Martyn, Gianluca Veggiani, Sachdev S Sidhu
Cells|August 26, 2023
Ubiquitin Engineering for Interrogating the Ubiquitin-Proteasome System and Novel Therapeutic StrategiesJason Q Tang, Mary M Marchand, Gianluca Veggiani
Pharmacology & Therapeutics|March 10, 2019
Emerging drug development technologies targeting ubiquitination for cancer therapeuticsGianluca Veggiani, María Carla Rosales Gerpe, Sachdev S Sidhu, et al.
Pageof 4